Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-18
1996-04-16
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530397, 530398, A61K 3824, A61K 3822, C07K 14575
Patent
active
055082610
ABSTRACT:
The present invention pertains to an alpha, beta-heterodimeric polypeptide having binding affinity to vertebrate luteinizing hormone (LH) receptors and vertebrate follicle stimulating hormone (FSH) receptors comprising a glycoprotein hormone alpha-subunit polypeptide and a non-naturally occurring beta-subunit polypeptide, wherein the beta-subunit polypeptide is a chain of amino acids comprising the following four joined subsequences:
(a) a first subsequence homologous to the amino acid sequence of residues 1-93 of the beta-subunit selected from the group consisting of human chorionic gonadotrophin (hCG), vertebrate luteinizing hormone (LH), vertebrate follicle stimulating hormone (FSH), and vertebrate thyroid stimulating hormone (TSH);
(b) a second subsequence homo logous to the amino acid sequence of residues 94-97 of the beta-subunit selected from the group consisting of human chorionic gonadotrophin (hCG) and vertebrate luteinizing hormone (LH);
(c) a third subsequence homologous to the amino acid sequence of residues 98-100 of the beta-subunit selected from the group consisting of human chorionic gonadotrophin (hCG), vertebrate luteinizing hormone (LH), vertebrate follicle stimulating hormone (FSH), and vertebrate thyroid stimulating hormone (TSH); and
(d) a fourth subsequence homologous to the amino acid sequence of residues 101-110 of the beta-subunit of vertebrate follicle stimulating hormone.
REFERENCES:
Matzuk et al., The Journal of Biological Chemistry, 264(5), 2409-2414, 1989.
Matzuk et al., The Journal of Biological Chemistry, 263(32), 17107-17111, 1988.
Bouslield et al. J. Biol. Chem. 263 12602-12067, 1988.
Rodgers et. al. J. Endocrinol. 129, 111.
Harlin et al. Fertil Steril. 46, 1055-1061, 1986.
Wallach et al. Fertil Steril 55, 478-480, 1991.
Schenher et al. Fertil Steril, 30 255-268, 1978.
Murphy et al. Endocrine Rev. 12, 27-44, 1991.
Campbell et al. Proc. Nat Acad, 88, 760-764, 1991.
Pierce et. al. Ann. Rev. Biochem, 50, 465-495, 1981.
Fiddes et al. Nature 286, 684-686, 1980.
Fiddes et. al. Nature 281 351--1980.
Keutmann. et al. Proc. Nat Acad, 84, 2038-2042, 1987.
Santa Colona et al. J. Biol Chem, 265, 5037-5042, 1990.
Schneyer et. al. Biochem, 27, 666-671, 1988.
Reddy et al. Proc. Nat. Acad. 83, 3644-3688, 1985.
Matzuk et. al. Proc Nat Acad, 84, 6354-6358, 1987.
Matzuk et al. Molec. Endocrinol., 2, 95-100, 1988.
Matzuk et al. J. Cell. Biol, 106, 1049-1059, 1988.
Moyle et. al. J. Biol. Chem., 265, 8511-8518, 1990.
Moyle et al. J. Biol Chem. 250 9163-9169, 1975.
Moyle et al. J. Receptor Research 8 419-436, 1988.
Campbell Robert K.
Han Yi
Macdonald Gordon J.
Moyle William R.
Wang Yanhong
Muccino Richard R.
Schain Howard E.
Touzeau Pfynn
University of Medicine & Dentistry of New Jersey
LandOfFree
Analogs of glycoprotein hormones having altered receptor binding does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analogs of glycoprotein hormones having altered receptor binding, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analogs of glycoprotein hormones having altered receptor binding will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-325169